In addition, current therapies used in HF, such as beta-blockers, ACE inhibitors and aldosterone antagonists, reduce myocardium oxygen demand and reduce dysfunction effect in metabolic vasodilation. This evidence concerns the gene ACE and hydrops fetalis.